促红细胞生成素诱导急性肾损伤时骨髓及血浆FGF23升高
本研究探讨急性肾损伤(AKI)时促红细胞生成素(EPO)是否通过刺激骨髓红系祖细胞表达FGF23而升高循环FGF23。在啮齿类出血性休克或脓毒症AKI模型中,血浆EPO快速升高,骨髓FGF23表达及循环FGF23迅速增加;阻断EPO受体可完全阻止骨髓FGF23诱导并部分抑制循环FGF23升高。严重脓毒症后48小时内发生AKI的患者中亦观察到循环FGF23与EPO早期升高。
要点
- 骨髓红系祖细胞表达FGF23,EPO通过同二聚体EPO受体增加其表达。
- 啮齿类AKI模型中血浆EPO快速升高,诱导骨髓FGF23并升高循环FGF23。
- 阻断EPO受体可完全阻止骨髓FGF23诱导,部分抑制循环FGF23升高。
核心结论
- 血浆EPO升高及EPO受体激活是AKI时循环FGF23升高的机制之一。
研究设计与样本
- 研究采用啮齿类出血性休克或脓毒症AKI模型、骨髓细胞培养及严重脓毒症患者队列。
主要发现
- 骨髓红系祖细胞表达FGF23,EPO在体内及骨髓细胞培养中经EPO受体增加FGF23表达。
- 啮齿类AKI模型中血浆EPO快速升高,伴骨髓FGF23表达诱导及循环FGF23快速增加。
- 阻断EPO受体完全阻止骨髓FGF23诱导,并部分抑制循环FGF23升高。
- 严重脓毒症后48小时内发生AKI的患者中,循环FGF23与EPO早期升高。
临床怎么用
- AKI早期循环FGF23升高部分由EPO驱动,评估FGF23时需考虑EPO水平影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is accepted that osteoblasts/osteocytes are the major source for circulating fibroblast growth factor 23 (FGF23). However, erythropoietic cells of bone marrow also express FGF23. The modulation of FGF23 expression in bone marrow and potential contribution to circulating FGF23 has not been well studied. Moreover, recent studies show that plasma FGF23 may increase early during acute kidney injury (AKI). Erythropoietin, a kidney-derived hormone that targets erythropoietic cells, increases in AKI. Here we tested whether an acute increase of plasma erythropoietin induces FGF23 expression in erythropoietic cells of bone marrow thereby contributing to the increase of circulating FGF23 in AKI. We found that erythroid progenitor cells of bone marrow express FGF23. Erythropoietin increased FGF23 expression in vivo and in bone marrow cell cultures via the homodimeric erythropoietin receptor. In experimental AKI secondary to hemorrhagic shock or sepsis in rodents, there was a rapid increase of plasma erythropoietin, and an induction of bone marrow FGF23 expression together with a rapid increase of circulating FGF23. Blockade of the erythropoietin receptor fully prevented the induction of bone marrow FGF23 and partially suppressed the increase of circulating FGF23. Finally, there was an early increase of both circulating FGF23 and erythropoietin in a cohort of patients with severe sepsis who developed AKI within 48 hours of admission. Thus, increases in plasma erythropoietin and erythropoietin receptor activation are mechanisms implicated in the increase of plasma FGF23 in AKI.
引用
- Toro L, Barrientos V, León P, et al. Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury. Kidney Int. 2018. PMID: 29395333. doi:10.1016/j.kint.2017.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。